Press Releases

The preliminary agenda for the 17th World ADC San Diego, taking place October 12–15, 2026, has been released, offering an exclusive first look at the scientific program for the world’s…
Read More...

Radiopharmaceuticals continue to reshape oncology strategy. Regeneron’s entry into radiopharma through its partnership with Telix investing $40M upfront across up to four oncology…
Read More...

As New Approach Methodologies (NAMs) and microphysiological systems (MPS) continue to gain momentum across drug development, the imperative facing industry scientists is increasingly…
Read More...

As antibody-drug conjugates (ADCs) continue to move into more complex payload classes and higher drug–antibody ratios, linker and conjugation chemistry remains a critical bottleneck for…
Read More...

Join the 3rd Biophysics for Drug Discovery Summit – The Countdown Is On! Biophysical methods underpin some of today’s most powerful drug discovery decisions — yet translating physical…
Read More...

Join the 5th Extrahepatic Lipid-Based Nanoparticles Delivery Summit As lipid-based therapeutics continue to advance, developers face growing pressure to deliver precise,…
Read More...

Ahead of the Investigative & Preclinical Toxicology Summit 2026, the dedicated Pre‑Conference Workshop Day is emerging as one of the most highly anticipated elements of the meeting,…
Read More...

The 5th In Vivo Cell Engineering & Gene Editing Summit returns to Boston this July, bringing together the scientific, translational, regulatory, and corporate leaders driving one of…
Read More...

Another major milestone has reshaped the T‑cell engager landscape. Vir Biotechnology and Astellas Pharma have entered a new global strategic partnership valued at $1.71 billion to…
Read More...

For fast‑growing digitalization leaders like Uncountable, accessing the right scientific and R&D decision makers is essential. Before joining the SmartLab Exchange USA, the company…
Read More...

Across materials science, chemistry, and pharmaceutical R&D, laboratories are moving beyond slow, sequential experimentation toward AI‑integrated discovery. One of the most…
Read More...

Exclusive Opportunity: Partner With the Leaders Defining the Future of the Digital Lab If your commercial strategy depends on reaching senior R&D leaders who are actively…
Read More...

Antibody-drug conjugate analytical development is entering a defining moment. As next-generation modalities, including bispecific ADCs, degrader conjugates, and dual-payload constructs,…
Read More...

After a successful gathering in Amsterdam earlier this year, the SmartLab Exchange USA will be hosted in a new city for 2026, making its Philadelphia debut this April. The Exchange…
Read More...

The Investigative & Preclinical Toxicology Summit (May 12-14 | Boston, MA) is set to redefine toxicology meetings for biotech and pharmaceutical professionals. Unlike traditional…
Read More...

The 5th LNP Summit, the only industry-led forum dedicated exclusively to end-to-end LNP development, is celebrating 5 years of running the flagship event. Bringing together leaders…
Read More...

As Medical Affairs continues to evolve into a strategic cornerstone of the biopharma industry, the ability to clearly define, measure, and communicate impact has never been more…
Read More...

January 27-29, 2026 | Boston, MA – With the exciting news of Novartis acquiring Avidity Biosciences, SanegeneBio and Eli Lilly's partnership worth $1.2B to develop RNAi therapeutics for…
Read More...

London, UK – The countdown is on for the 7th Annual AI in Drug Discovery Conference, taking place 9th-10th March 2026 in London. Delegates have until 5th December to secure a £200…
Read More...

April 6-8, 2026 | Boston, MA – Against a backdrop of major industry acquisitions including AbbVie/Capstan Therapeutics, Eli Lilly & Co/Verve Therapeutics, and now BMS/Orbital…
Read More...